Ani Pharmaceuticals Stock Today
| ANIP Stock | USD 64.58 0.90 1.37% |
Performance10 of 100
| Odds Of DistressLess than 1
|
ANI Pharmaceuticals is selling at 64.58 as of the 18th of April 2024; that is -1.37% down since the beginning of the trading day. The stock's last reported lowest price was 64.43. ANI Pharmaceuticals has a very small chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for ANI Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of May 2000 | Category Healthcare | Classification Health Care |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota. The company has 20.98 M outstanding shares of which 197.03 K shares are presently shorted by private and institutional investors with about 0.95 trading days to cover. More on ANI Pharmaceuticals
Moving together with ANI Stock
| 0.91 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.71 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
| 0.75 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
Moving against ANI Stock
| 0.97 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.91 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.89 | ME | 23Andme Holding | PairCorr |
| 0.89 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.87 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.75 | DRTS | Alpha Tau Medical Financial Report 28th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 13th of May 2024
ANI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ANI Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ANI Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Nikhil Lalwani | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering ANI Pharmaceuticals report their recommendations after researching ANI Pharmaceuticals' financial statements, talking to executives and customers, or listening in on ANI Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering ANI Pharmaceuticals. The ANI consensus assessment is calculated by taking the average forecast from all of the analysts covering ANI Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to ANI Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, ANI Pharmaceuticals is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of ANI Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANI Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ANI Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ANI Pharmaceuticals' financial leverage. It provides some insight into what part of ANI Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANI Pharmaceuticals (ANIP) is traded on NASDAQ Exchange in USA. It is located in 210 Main Street West, Baudette, MN, United States, 56623 and employs 642 people. ANI Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ANI Pharmaceuticals's market, we take the total number of its shares issued and multiply it by ANI Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ANI Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 20.98 M outstanding shares of which 197.03 K shares are presently shorted by private and institutional investors with about 0.95 trading days to cover.
ANI Pharmaceuticals currently holds about 63.38 M in cash with 118.96 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.89.
Check ANI Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationANI Pharmaceuticals holds a total of 20.98 Million outstanding shares. The majority of ANI Pharmaceuticals outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in ANI Pharmaceuticals to benefit from reduced commissions. Thus, institutional investors are subject to a different set of regulations than regular investors in ANI Pharmaceuticals. Please pay attention to any change in the institutional holdings of ANI Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ANI Ownership Details
ANI Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of ANI Pharmaceuticals jumping above the current price in 90 days from now is about 33.23%. The ANI Pharmaceuticals probability density function shows the probability of ANI Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days ANI Pharmaceuticals has a beta of 0.8282. This suggests as returns on the market go up, ANI Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ANI Pharmaceuticals will be expected to be much smaller as well. Additionally, aNI Pharmaceuticals has an alpha of 0.19, implying that it can generate a 0.19 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of ANI Pharmaceuticals to move above the current price in 90 days from now is about 33.23 (This ANI Pharmaceuticals probability density function shows the probability of ANI Stock to fall within a particular range of prices over 90 days) .
ANI Stock Institutional Holders
Institutional Holdings refers to the ownership stake in ANI Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ANI Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ANI Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Ameriprise Financial Inc | 2023-12-31 | 236.4 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 231.9 K | |
| Macquarie Group Ltd | 2023-12-31 | 230.1 K | |
| Kennedy Capital Management Inc | 2023-12-31 | 229 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 224 K | |
| Thompson, Siegel & Walmsley Llc | 2023-12-31 | 212.9 K | |
| Loomis, Sayles & Company Lp | 2023-12-31 | 180.4 K | |
| Northern Trust Corp | 2023-12-31 | 167.1 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 159.3 K | |
| Blackrock Inc | 2023-12-31 | 2.5 M | |
| Vanguard Group Inc | 2023-12-31 | 1.3 M |
ANI Pharmaceuticals Historical Income Statement
ANI Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting ANI's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ANI Pharmaceuticals revenue and expense. ANI Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, ANI Pharmaceuticals' EBIT is relatively stable compared to the past year. As of 04/18/2024, Research Development is likely to grow to about 36 M, while Non Recurring is likely to drop slightly above 3.8 M. View More FundamentalsANI Stock Against Markets
Picking the right benchmark for ANI Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ANI Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ANI Pharmaceuticals is critical whether you are bullish or bearish towards ANI Pharmaceuticals at a given time. Please also check how ANI Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ANI Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
ANI Pharmaceuticals Corporate Directors
ANI Pharmaceuticals corporate directors refer to members of an ANI Pharmaceuticals board of directors. The board of directors generally takes responsibility for the ANI Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ANI Pharmaceuticals' board members must vote for the resolution. The ANI Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| David Nash | Independent Director | Profile | |
| Daniel Raynor | Director | Profile | |
| Thomas Haughey | Independent Director | Profile | |
| Patrick Walsh | Independent Director | Profile |
How to buy ANI Stock?
Before investing in ANI Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ANI Pharmaceuticals. To buy ANI Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ANI Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ANI Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ANI Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ANI Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as ANI Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy ANI Stock please use our How to Invest in ANI Pharmaceuticals guide.
Already Invested in ANI Pharmaceuticals?
The danger of trading ANI Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ANI Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ANI Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ANI Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for ANI Stock analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Earnings Share 0.85 | Revenue Per Share 27.044 | Quarterly Revenue Growth 0.397 | Return On Assets 0.0372 |
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.